Cobaltous Chloride

CHEMBL1909055 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
129.8 g/mol
LogP
Phase
4

An inorganic cobalt compound that has been studied for its effects on red blood cell production. It has been used experimentally but is not widely approved due to potential toxicity.

Berat Molekul

129,8400 g/mol

TPSA

0,00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[Cl-].[Cl-].[Co+2]

InChI

InChI=1S/2ClH.Co/h2*1H;/q;;+2/p-2

Molecular Formula

Cl2Co

HBD / HBA

- / 2

Ikatan yang Dapat Dirotasi

0

Atom Berat

3

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

An inorganic cobalt compound that has been studied for its effects on red blood cell production. It has been used experimentally but is not widely approved due to potential toxicity.

Yes, Cobaltous Chloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1909055. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3032536. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.